Benchmark analyst Bruce Jackson lowered the price target on Harvard Bioscience Inc. (NASDAQ: HBIO) to $4.50 (from $5.50) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE